Torno Capital, LLC Glycomimetics Inc Transaction History
Torno Capital, LLC
- $2.13 Trillion
- Q2 2024
A detailed history of Torno Capital, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Torno Capital, LLC holds 74,700 shares of GLYC stock, worth $30,626. This represents 0.0% of its overall portfolio holdings.
Number of Shares
74,700Holding current value
$30,626% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GLYC
# of Institutions
41Shares Held
25.6MCall Options Held
1.94MPut Options Held
153K-
Bvf Inc San Francisco, CA9.54MShares$3.91 Million0.08% of portfolio
-
Artal Group S.A. Luxembourg, N48.59MShares$3.52 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.7MShares$1.11 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny827KShares$339,0080.0% of portfolio
-
Goldman Sachs Group Inc New York, NY804KShares$329,7800.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $21.5M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...